Update April, 2017: This study is now open to patients 6 years and older (previously 13)
Rettland Foundation may provide travel assistance from Ontario to the Chicago site.
Is your child living with Rett Syndrome
There is a research trial to evaluate the safety, tolerability and efficacy of an investigational drug in reducing respiratory abnormalities in patients with Rett Syndrome.
Patients may be eligible who:
* are 6 years and older,
* have a body weight of at least 10 kg (22 lbs), and
* experience multiple episodes of breath holding (apnea) while awake during the day
The study is being conducted at the following locations. If you are interested to learn more about this study please see the link, https://clinicaltrials.gov/ct2/show/NCT02790034?term=newron&rank=2 or contact the site nearest to you.
University of Alabama at Birmingham
Call Jane Lane at 205-996-4927 or Email: email@example.com
Principal Investigator: Alan Percy, MD
Altman Clinical and Translation Research Institute, La Jolla, San Diego
Call Karen Ditslear at 858-246-2288 or Email: firstname.lastname@example.org
Principal Investigator: Jeffrey Neul, MD, PhD
Rush Medical University Center, Chicago
Call Susan Rohde at 312-942-0079 or Email: email@example.com
Principal Investigator: Peter Heydemann, MD
Texas Children Hospital, Houston
Call Mohammad Naqvi at 832-824-3634 or Email: Mohammad.Naqvi@bcm.edu
Principal Investigator: Daniel Glaze, MD
Copyright © 2021 · All Rights Reserved · Ontario Rett Syndrome Association | O.R.S.A.
NonProfit Theme v5 by Organic Themes · WordPress Hosting · RSS Feed · Log in